ALFA Filings
Every announcement, straight from the exchange
Every Vivo Bio Tech other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
The company submitted its periodic shareholding pattern for the quarter ended September 30, 2026, disclosing its promoter and public shareholding as mandated by SEBI.
Vivo Bio Tech Ltd filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Vivo Bio Tech has sent letters to shareholders without registered email addresses, providing a web-link to access the Annual Report for the financial year 2025-26.
Vivo Bio Tech Ltd filed its routine quarterly shareholding pattern for the period ending June 30, 2026.
Vivo Bio Tech Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. This filing fulfills regulatory disclosure requirements under SEBI (LODR) Regulations.